Showing 2931-2940 of 7861 results for "".
Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.A Novel Topical Cream to Reduce Bruising
https://practicaldermatology.com/topics/general-topics/a-novel-topical-cream-to-reduce-bruising/21476/Although options to treat bruising have been limited, a new cream may be especially useful for older patients.A Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.Reducing Atopic March Risk in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, is joined by Editorial Board member Peter Lio, MD, to analyze the Journal of the American Academy of Dermatology article "Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus cOn Purpose, Pediatrics, and Pioneering Care A Conversation with Dr. Lisa Swanson
https://practicaldermatology.com/issues/july-2025/on-purpose-pediatrics-and-pioneering-care-a-conversation-with-dr-lisa-swanson/36514/Young MD Connect recently hosted a mentorship session with pediatric dermatologist Dr. Lisa Swanson to learn from a practicing professional in the field of dermatology in a relaxed “Ask Me Anything” setting.Close Up With Emma Guttman-Yassky, MD, PhD
https://practicaldermatology.com/topics/close-up/close-up-with-emma-guttman-yassky-md-phd/23953/Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.